Urology
Volume 68, Issue 4 , Pages 800-803, October 2006

Is high-grade prostatic intraepithelial neoplasia on needle biopsy different in an Asian population: A clinicopathologic study performed in Singapore

  • Puay Hoon Tan

      Affiliations

    • Department of Pathology, Singapore General Hospital, Singapore
    • Corresponding Author InformationReprint requests: Puay Hoon Tan, M.D., Department of Pathology, Singapore General Hospital, Outram Road, Singapore 169608 Singapore.
  • ,
  • Hong Wui Tan

      Affiliations

    • Department of Pathology, Singapore General Hospital, Singapore
  • ,
  • Yen Tan

      Affiliations

    • Department of Pathology, Singapore General Hospital, Singapore
  • ,
  • Chay Ngee Lim

      Affiliations

    • Department of Pathology, Singapore General Hospital, Singapore
  • ,
  • Christopher Cheng

      Affiliations

    • Department of Urology, Singapore General Hospital, Singapore
  • ,
  • Jonathan I. Epstein

      Affiliations

    • Department of Pathology, Urology, and Oncology, Johns Hopkins Hospital, Baltimore, Maryland

Received 17 November 2005; accepted 25 April 2006.

Abstract 

Objectives

To evaluate the incidence, pathologic findings, and follow-up of high-grade prostatic intraepithelial neoplasia (HGPIN) in a series of prostate core biopsies from Singaporean men.

Methods

We studied isolated HGPIN diagnosed on prostate core biopsies and the incidence of cancer discovered in men who had undergone repeat biopsies from 1999 to 2003 at the Department of Pathology, Singapore General Hospital.

Results

Of 1219 men undergoing prostate needle biopsy, 56 (4.6%) had isolated HGPIN. Most cases affected a single prostate core (44 cases, 78.6%). Twenty-nine men (51.8%) underwent repeat biopsies. Cancer was discovered in 7 (24.1%) of the 29 men within two repeat biopsies.

Conclusions

The incidence of isolated HGPIN on prostate needle core biopsies in Asian men, as well as the likelihood of subsequent cancer detection, are comparable to the rates reported for Western populations. The relatively low yield of cancer detection on repeat biopsy supports the need to re-evaluate recommendations for rebiopsy strategies.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0090-4295(06)00618-2

doi:10.1016/j.urology.2006.04.026

Urology
Volume 68, Issue 4 , Pages 800-803, October 2006